The India Fund , Inc. And The Asia Tigers Fund, Inc. Announce Director Resignation
Enanta Pharmaceuticals Announces AbbVie’s Investigational Treatment Regimen for Genotype 1 Chronic Hepatitis C Granted Priority Review in Japan
AbbVie's Investigational Chronic Hepatitis C Treatment Granted Priority Review in Japan
Entreprenörskapsforum: Research on Evolutionary Economics Rewarded with 100 000 Euros
We take a close look at the fund options.
We take a closer look at India, Taiwan, and Malaysia.
The Bond King's departure had a small impact on CEF performance compared with the onslaught in the commodities market.
Appears to be priced in, for now.
Despite the market's wild ride, most CEFs closed the year with positive share price and NAV returns.